Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).